Review: could Depo-provera cause Pulmonary Embolism?


Pulmonary embolism is found among people who take Depo-Provera, especially for people who are female, 20-29 old , have been taking the drug for < 1 month, also take medication Yaz, and have Contraception . We study 9,649 people who have side effects while taking Depo-provera from FDA and social media. Among them, 183 have Pulmonary embolism. Find out below who they are, when they have Pulmonary embolism and more.

You are not alone

Join a support group for people who take Depo-provera and have Pulmonary embolism >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Depo-provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. (latest outcomes from Depo-provera 10,604 users)

Pulmonary Embolism

Pulmonary embolism (blockage of the main artery of the lung) has been reported by people with breathing difficulty, fever, hypotension, international normalised ratio increased, chest pain (latest reports from 67,581 Pulmonary embolism patients).

On Aug, 17, 2016

9,649 people reported to have side effects when taking Depo-provera.
Among them, 183 people (1.9%) have Pulmonary Embolism

Number of reports submitted per year:

Could Depo-provera cause Pulmonary embolism?

Time on Depo-provera when people have Pulmonary Embolism *:

  • < 1 month: 54.76 %
  • 1 - 6 months: 11.9 %
  • 6 - 12 months: 7.14 %
  • 1 - 2 years: 2.38 %
  • 2 - 5 years: 11.9 %
  • 5 - 10 years: 9.52 %
  • 10+ years: 2.38 %

Gender of people who have Pulmonary Embolism when taking Depo-provera *:

  • female: 98.87 %
  • male: 1.13 %

Age of people who have Pulmonary Embolism when taking Depo-provera *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 15.0 %
  • 20-29: 49.38 %
  • 30-39: 23.75 %
  • 40-49: 9.38 %
  • 50-59: 2.5 %
  • 60+: 0.0 %

Top conditions involved for these people *:

  • Contraception (81 people)
  • Premenstrual Syndrome (9 people)
  • Headache (9 people)
  • Pulmonary Embolism (8 people)
  • Acne (8 people)

Top co-used drugs for these people *:

  • Yaz (45 people)
  • Yasmin (34 people)
  • Ibuprofen (22 people)
  • Nuvaring (18 people)
  • Lovenox (15 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Pulmonary embolism when taking Depo-provera?

Browse all side effects of Depo-provera

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Pulmonary embolism

Pulmonary embolism

Could your condition cause Pulmonary embolism

Pulmonary embolism

Can you answer these questions?

More questions for: Depo-provera, Pulmonary embolism

You may be interested in these reviews

More reviews for: Depo-provera, Pulmonary embolism

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.